ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 244 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $6,298,206 | +6.0% | 220,217 | +13.4% | 0.02% | -4.2% |
Q4 2023 | $5,942,765 | +10.2% | 194,208 | -3.2% | 0.02% | -31.4% |
Q3 2023 | $5,390,633 | -27.9% | 200,619 | -4.3% | 0.04% | -23.9% |
Q2 2023 | $7,475,477 | +36.4% | 209,632 | -2.8% | 0.05% | +27.8% |
Q1 2023 | $5,479,034 | -36.4% | 215,710 | +1.5% | 0.04% | -40.0% |
Q4 2022 | $8,617,215 | +21.4% | 212,456 | -1.1% | 0.06% | +15.4% |
Q3 2022 | $7,099,000 | -9.1% | 214,794 | -3.1% | 0.05% | -1.9% |
Q2 2022 | $7,808,000 | -25.7% | 221,769 | -3.0% | 0.05% | -8.6% |
Q1 2022 | $10,511,000 | -30.8% | 228,541 | -0.2% | 0.06% | -23.7% |
Q4 2021 | $15,187,000 | +4.0% | 229,063 | -2.1% | 0.08% | -2.6% |
Q3 2021 | $14,601,000 | -26.7% | 233,877 | -2.7% | 0.08% | +16.4% |
Q2 2021 | $19,910,000 | +20.5% | 240,400 | -3.5% | 0.07% | +15.5% |
Q1 2021 | $16,516,000 | -12.3% | 249,077 | +1.5% | 0.06% | -17.1% |
Q4 2020 | $18,825,000 | +77.6% | 245,335 | -0.3% | 0.07% | +37.3% |
Q3 2020 | $10,601,000 | -1.9% | 246,187 | -1.6% | 0.05% | -1.9% |
Q2 2020 | $10,807,000 | +48.5% | 250,211 | -1.0% | 0.05% | +30.0% |
Q1 2020 | $7,275,000 | -54.1% | 252,853 | +1.1% | 0.04% | -34.4% |
Q4 2019 | $15,864,000 | +710.6% | 250,099 | +260.2% | 0.06% | +662.5% |
Q3 2019 | $1,957,000 | +5.2% | 69,443 | -1.0% | 0.01% | +14.3% |
Q2 2019 | $1,860,000 | +69.7% | 70,173 | +17.5% | 0.01% | +75.0% |
Q1 2019 | $1,096,000 | +53.9% | 59,708 | +4.2% | 0.00% | +33.3% |
Q4 2018 | $712,000 | -35.7% | 57,305 | -0.8% | 0.00% | -25.0% |
Q3 2018 | $1,107,000 | +43.6% | 57,745 | +1.8% | 0.00% | +33.3% |
Q2 2018 | $771,000 | +1001.4% | 56,705 | +50.9% | 0.00% | – |
Q1 2017 | $70,000 | +29.6% | 37,574 | +8.0% | 0.00% | – |
Q4 2016 | $54,000 | -100.0% | 34,802 | -0.3% | 0.00% | -100.0% |
Q3 2016 | $256,464,000 | +38.4% | 34,893 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $185,349,000 | +10.3% | 34,840 | -0.0% | 0.00% | 0.0% |
Q1 2016 | $168,000,000 | – | 34,846 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ELEMENT CAPITAL MANAGEMENT LLC | 142,649 | $618,000 | 0.25% |
ING GROEP NV | 808,229 | $3,500,000 | 0.07% |
A.R.T. Advisors, LLC | 232,470 | $1,006,000 | 0.05% |
OppenheimerFunds, Inc. | 3,000,000 | $12,990,000 | 0.02% |
Edge Wealth Management LLC | 10,000 | $43,000 | 0.01% |
First Allied Advisory Services, Inc. | 61,000 | $264,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 200,000 | $866,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 1,272,138 | $5,508,000 | 0.01% |
D. E. Shaw & Co., Inc. | 971,768 | $4,208,000 | 0.01% |
Virtu Financial LLC | 18,008 | $78,000 | 0.00% |